The Effect of a Resistance Training Program in Healthcare Workers on Pain, Workability and Physical Function.

The Effect of a Brief Daily Resistance Training Program in Healthcare Workers on Pain, Workability and Physical Function.

The prevalence and consequences of musculoskeletal pain is considerable among healthcare workers, allegedly due to high physical work demands of healthcare work.

Performing physical exercise at the workplace together with colleagues may be more motivating for some employees and thus increase adherence. On the other hand, physical exercise performed during working hours at the workplace may be costly for the employers in terms of time spend. Thus, it seems relevant to perform a brief intervention. This study is intended to investigate the difference between the effect of workplace-based physical exercise (using elastic bands and body weight exercises) and a group control on musculoskeletal pain, physical exertion during work, physical function, need for recovery, self-rated use of analgesics, and work ability among healthcare workers.

Study Overview

• Status: Completed
• Conditions: Musculoskeletal Pain; Physical Function; Work Ability
• Intervention / Treatment: Other: Resistance training

• Study Type: Interventional
• Enrollment (Actual): 37
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Spain
  • Valencia, Spain, 46010
    • Clinic Universitary Hospital of Valencia

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Healthcare Workers at the Hospital
• Informed consent

Exclusion Criteria:

• Unable to perform exercises

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Intervention; 15 minutes of resistance training at the work place every day	Other: Resistance training; 15 minutes of resistance training during work every day
No Intervention: Control; Usual work

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain overall status: Standard 7-point patient global impression	Standard 7-point patient global impression of pain collected at the endpoint	2 days after the end of intervention (POST)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Workability Index	Questionnaire work ability	Baseline
Workability Index	Questionnaire work ability	2 days after the end of intervention (POST)
Physical function	Physical tests (push-ups, Biering-Sorensen test, Sit to Stand)	Baseline
Physical function	Physical tests (push-ups, Biering-Sorensen test, Sit to Stand)	2 days after the end of intervention (POST)
Perceived physical exertion	Based on Borg's rate of perceived exertion (RPE) (Borg CR10 scale)	Baseline
Perceived physical exertion	Based on Borg's rate of perceived exertion (RPE) (Borg CR10 scale)	3 weeks of resistance training
Perceived physical exertion	Based on Borg's rate of perceived exertion (RPE) (Borg CR10 scale)	6 weeks of resistance training
Perceived physical exertion	Based on Borg's rate of perceived exertion (RPE) (Borg CR10 scale)	2 days after the end of intervention (POST)
"Need for recovery scale" after work	Five point scale (1 = never, 5 = always)	Baseline
"Need for recovery scale" after work	Five point scale (1 = never, 5 = always)	3 weeks of resistance training
"Need for recovery scale" after work	Five point scale (1 = never, 5 = always)	6 weeks of resistance training
"Need for recovery scale" after work	Five point scale (1 = never, 5 = always)	2 days after the end of intervention (POST)
Self-rated use of analgesics	The number of days the participants used analgesics during the last week	Baseline
Self-rated use of analgesics	The number of days the participants used analgesics during the last week	3 weeks of resistance training
Self-rated use of analgesics	The number of days the participants used analgesics during the last week	6 weeks of resistance training
Self-rated use of analgesics	The number of days the participants used analgesics during the last week	2 days after the end of intervention (POST)
Pain: Average pain intensity (Visual Analogue Scale (VAS) Scale 0-10)	Average pain intensity (Visual Analogue Scale (VAS) Scale 0-10, 0 = not pain, 10 = worst possible pain)	Baseline
Pain: Average pain intensity (Visual Analogue Scale (VAS) Scale 0-10)	Average pain intensity (Visual Analogue Scale (VAS) Scale 0-10, 0 = not pain, 10 = worst possible pain)	3 weeks of resistance training
Pain: Average pain intensity (Visual Analogue Scale (VAS) Scale 0-10)	Average pain intensity (Visual Analogue Scale (VAS) Scale 0-10, 0 = not pain, 10 = worst possible pain)	6 weeks of resistance training
Pain: Average pain intensity (Visual Analogue Scale (VAS) Scale 0-10)	Average pain intensity (Visual Analogue Scale (VAS) Scale 0-10, 0 = not pain, 10 = worst possible pain)	2 days after the end of intervention (POST)

Collaborators and Investigators

• Sponsor: University of Valencia
• Investigators: Study Chair: Jose C Granell, PhD, University of Valencia

Study record dates

Study Major Dates

• Study Start (Actual): April 17, 2018
• Primary Completion (Actual): June 19, 2018
• Study Completion (Actual): June 19, 2018

Study Registration Dates

• First Submitted: March 13, 2018
• First Submitted That Met QC Criteria: April 16, 2018
• First Posted (Actual): April 18, 2018

Study Record Updates

• Last Update Posted (Actual): October 8, 2019
• Last Update Submitted That Met QC Criteria: October 5, 2019
• Last Verified: October 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Musculoskeletal Diseases; Muscular Diseases; Musculoskeletal Pain
• Other Study ID Numbers: 0000260894

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No